Brand Name | Status | Last Update |
---|---|---|
signifor | New Drug Application | 2024-07-16 |
signifor lar | New Drug Application | 2024-07-16 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
cushing syndrome | EFO_0003099 | D003480 | E24 |
Expiration | Code | ||
---|---|---|---|
PASIREOTIDE PAMOATE, SIGNIFOR LAR KIT, RECORDATI RARE | |||
2025-06-29 | ODE-268 |
Code | Description |
---|---|
J2502 | Injection, pasireotide long acting, 1 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pituitary acth hypersecretion | D047748 | EFO_1001110 | E24.0 | — | — | — | 1 | 1 | 2 |
Acth-secreting pituitary adenoma | D049913 | — | — | — | — | — | 1 | 1 | 2 |
Neuroendocrine tumors | D018358 | EFO_1001901 | D3A.8 | — | 1 | — | 1 | — | 2 |
Prostatic neoplasms | D011471 | — | C61 | — | — | — | 1 | — | 1 |
Melanoma | D008545 | — | — | — | — | — | 1 | — | 1 |
Pituitary neoplasms | D010911 | — | — | — | — | — | 1 | — | 1 |
Pituitary diseases | D010900 | — | E23.7 | — | — | — | 1 | — | 1 |
Dumping syndrome | D004377 | EFO_1001307 | K91.1 | — | — | — | 1 | — | 1 |
Acromegaly | D000172 | — | — | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neoplasms | D009369 | — | C80 | — | 1 | — | — | — | 1 |
Carcinoid tumor | D002276 | — | D3A.00 | — | 1 | — | — | — | 1 |
Hypoglycemia | D007003 | — | E16.2 | — | 1 | — | — | — | 1 |
Drug common name | Pasireotide |
INN | pasireotide |
Description | Pasireotide is a six-membered homodetic cyclic peptide composed from L-phenylglycyl, D-tryptophyl, L-lysyl, O-benzyl-L-tyrosyl, L-phenylalanyl and modified L-hydroxyproline residues joined in sequence. A somatostatin analogue with pharmacologic properties mimicking those of the natural hormone somatostatin; used (as its diaspartate salt) for treatment of Cushing's disease. It has a role as an antineoplastic agent. It is a homodetic cyclic peptide and a peptide hormone. It is a conjugate base of a pasireotide(2+). |
Classification | Protein |
Drug class | peptides: inhibition of growth hormone release |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2C[C@H](OC(=O)NCCN)CN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(OCc3ccccc3)cc2)NC1=O |
PDB | — |
CAS-ID | 396091-73-9 |
RxCUI | — |
ChEMBL ID | CHEMBL3039583 |
ChEBI ID | — |
PubChem CID | 9941444 |
DrugBank | DB06663 |
UNII ID | 98H1T17066 (ChemIDplus, GSRS) |